Emerging drug discovery paradigm in non small cell lung cancer: pharmacophore modeling, atom-based 3D- QSAR and virtual screening of novel EGFR inhibitors

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 12

Abstract

EGFR is a significant drug target approached in the domain of the wide prevailing cancer type, non- small cell lung cancer and search for its potent inhibitor is an emerging opportunity in cancer drug discovery. Computational framework of our study outsmarts the existing strategies and new insight into EGFR inhibitors. To figure out the higher biological behavior of the N-benzyl-N-(X-2-hydroxybenzyl)-N0-phenylureas and thioureas derivatives, functional spots requirement were substantially discovered using pharmacophore modeling and atom- based 3D-QSAR. Having the eye on five crucial pharmacophore features AADHR: namely two acceptors (A), one hydrogen bond donor (D), one hydrophobic group (H), one aromatic ring (R), then unique pharmacophore was identified. As the succession of this pharmacophore concept, statistical parameters for better construction of best model, correlation coefficient R2 =0.9803 for training set compounds and Q2=0.7099 for test set compounds were outcome of the atom based 3D-QSAR analysis. Then we engaged with virtual screening method to screen existing drug molecules of zinc database to identify exceedingly capable inhibitor for EGFR. Ultimately, scaffold with distinct qualities for drug-like species, top four of them were reported.

Authors and Affiliations

Joseph Gerad Rakesh| Department of Microbiology, Sri Venkateshwaara Medical College Hospital and Research Centre, Ariyur, Puducherry – 605102., Bappunhi Shaheera| SNMV College of Arts and Science, Malumichampatti, Coimbatore–641 021, India., Palani Aarumugam| Vector Control Research Centre (VCRC), Medical Complex, Indira Nagar, Puducherry–605006, India., Ramamurthi Vaiyshnavi| Sri Venkateswara College of Engineering, Sriperumbudur, Chennai-602 117, India., Ramamoorthy Thulasibabu*

Keywords

Related Articles

BIOCHEMICAL BASIS FOR USE OF CANNABINOIDS IN VARIOUS CLINICAL CONDITIONS

The broad range of potential therapeutic applications of cannabinoids reflects the wide distribution of cannabinoid receptors throughout the body. The possibility of distinct subtypes of cannabinoid receptors and the pr...

DETRIMENTAL IMPACTS OF TOXIC INGREDIENTS FOUND IN COLAS

The pesticides-in-cola saga continues. The health ministry’s expert committee states Coke and Pepsi are safe, and has trashed the testing methodology of Centre for Science and Environment (CSE), the NGO that claimed to...

A rare case of flupirtine induced loss of speech.

Anarthria can be caused by CNS depressant drugs but flupirtine consumption leading to it, is not documented till date. Since it is a drug with unique properties and is being more commonly used by practitioners, caution n...

Semester performance index and cumulative performance index: the latest grading of marks in mark sheets of semester system in technical courses

A "semester" (from the Latin meaning "six-monthly") has come to mean either of two academic terms, generally excluding the summer or January terms, if any, and so can be 12 to 20 weeks long. The word "semester" is someti...

CORRELATION BETWEEN CHEMINFORMATICS AND BIOINFORMATICS IN DRUG DISCOVERY: A FARSIGHT OF PHARMACY-THE MILLENNIUM OATH

All drugs are chemicals but all chemicals are not drugs….This statement always focuses towards the footsteps of a new drug discovery by information technology which is concerned with the drug designing which is followed...

Download PDF file
  • EP ID EP1554
  • DOI -
  • Views 401
  • Downloads 24

How To Cite

Joseph Gerad Rakesh, Bappunhi Shaheera, Palani Aarumugam, Ramamurthi Vaiyshnavi (2014). Emerging drug discovery paradigm in non small cell lung cancer: pharmacophore modeling, atom-based 3D- QSAR and virtual screening of novel EGFR inhibitors. Journal of Drug Discovery and Therapeutics, 2(12), 9-17. https://europub.co.uk/articles/-A-1554